Exelixis and Invenra Enter Into Collaboration to Discover and Develop Novel Biologics to Treat Cancer Read more
Bioniz Therapeutics Announces Positive Phase 1b Clinical Study Results for Investigational Agent BNZ-1 Read more
Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab Read more
Over 20 presentations on developments in the field of analgesic medicine at the SMi event in London Read more